-
Feb.232015NEWS
HanAll Biopharma, Applied the Clinical Trial Phase 1 for New Medicine of Dry Eye Diseases
HanAll Biopharma, Applied the Clinical Trial Phase 1 for New Medicine of Dry Eye Diseases
-
Jan.072015NEWS
HanAll Biopharma Sponsors 17 million KRW worth Daily Supplies to Patients with Xerosis
HanAll Biopharma Sponsors 17 million KRW worth Daily Supplies to Patients with Xerosis
-
Jan.072015NOTICE
HanAll Biopharma Sponsors Medicines worth 82 million KRW to Community Chest of Korea
HanAll Biopharma Sponsors Medicines worth 82 million KRW to Community Chest of Korea
-
Dec.092014NEWS
Hanall Biopharma Received the \'2014 Grand Prize of King Sejong Voluntary Service of Sharing\'
Hanall Biopharma Received the \'2014 Grand Prize of King Sejong Voluntary Service of Sharing\'
-
Dec.012014NEWS
HanAll is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
HanAll is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
-
Nov.212014NEWS
HanAll Biopharma Records Surplus for Three Consecutive Quarter
HanAll Biopharma Records Surplus for Three Consecutive Quarter